It is specifically labeled as Bacteriostatic Water for Injection, indicating the inclusion of benzyl alcohol as a bacteriostatic preservative
For the first time, a pharmacological obesity treatment, semaglutide (at a weekly dose of 2.4 mg), has been shown to reduce major adverse cardiovascular events in people with obesity and established cardiovascular disease
Its small-molecule structure makes it more stable and easier to produce
This is different from a compounded formula, which is not FDA approved and where little research currently exists surrounding safety and efficacy.53 Patients using compounded versions may not receive a standardized dose, and safety and efficacy data for these products is currently lacking
Biohackr Health provides thoughtful, evidence-based menopause and perimenopause care for women across San Francisco, Palo Alto, and the Bay Area